In the phase 3 LIBERTY study, the investigational monoclonal antibody, VYD2311, had significantly fewer adverse events than an mRNA COVID-19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the two were given together.
|Articles|December 3, 2020
Moderna COVID-19 Vaccine Maintains Elevated Antibodies Over Time
Author(s)John Parkinson
While the antibodies declined slightly at 3 months, all participants showed elevated levels.
Advertisement
In a Letter to the Editor published today in the
The vaccine, administered at the 100-μg dosage, was shown to produce high levels of binding and neutralizing antibodies that declined slightly over time.
“At the day 119 time point, the geometric mean titer (GMT) was 235,228 (95% confidence interval [CI], 177,236 to 312,195) in participants 18 to 55 years of age, 151,761 (95% CI, 88,571 to 260,033) in those 56 to 70 years of age, and 157,946 (95% CI, 94,345 to 264,420) in those 71 years of age or older,” the investigators wrote.
The investigators said that while lasting protection against the virus is unknown, the Moderna vaccine may offer long-term immunity.
“These results show that despite a slight expected decline in titers of binding and neutralizing antibodies, mRNA-1273 has the potential to provide durable humoral immunity,” they wrote.
They also stated participants did not suffer any serious adverse events during the trial or after day 57.
The Moderna vaccine is a nucleoside-modified messenger RNA (mRNA) platform that is encoded for a prefusion stabilized form of the SARS-CoV-2 spike protein.
The company announced earlier this week it was going to submit its vaccine to the US Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA). Its meeting is scheduled for December 17, and a potential approval could happen shortly thereafter.
Advertisement
Related to this article
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
Serial bloodstream isolates from two critically ill London patients showed heteroresistance, CRZ1 escape mutations, and drug-induced polyploidy despite wild-type FKS1 and susceptible MICs.
Projected disease burden from declining childhood vaccine coverage shows increases in vaccine-preventable diseases. Benjamin Lopman, PhD, provides insights on how VaxImpactMap works and the potential long-term disease consequences of decreased immunization rates.
Approximately 12% of all new cases of cancer worldwide in 2024 were attributable to an infection, with most of the infections preventable or treatable before cancer develops.
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.
North Carolina health officials confirmed two West Nile virus deaths among adults in the central part of the state, where CDC data show 11 human cases this season.
A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.
Advertisement
Advertisement